Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | dihydropyrimidine dehydrogenase NADP | 0.0731 | 0.3586 | 1 |
Entamoeba histolytica | dihydropyrimidine dehydrogenase, putative | 0.0731 | 0.3586 | 1 |
Echinococcus granulosus | poly ADP ribose polymerase 1 | 0.0289 | 0.1102 | 0.2697 |
Trypanosoma brucei | dihydroorotate dehydrogenase (fumarate) | 0.1871 | 1 | 1 |
Brugia malayi | Zinc finger, C2H2 type family protein | 0.0731 | 0.3586 | 0.3082 |
Echinococcus multilocularis | dihydropyrimidine dehydrogenase (NADP+) | 0.0731 | 0.3586 | 1 |
Mycobacterium ulcerans | dihydroorotate dehydrogenase 2 | 0.1871 | 1 | 0.5 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.1871 | 1 | 1 |
Schistosoma mansoni | dihydroorotate dehydrogenase | 0.1871 | 1 | 1 |
Schistosoma mansoni | poly [ADP-ribose] polymerase | 0.0223 | 0.0729 | 0.0179 |
Mycobacterium tuberculosis | Probable dihydroorotate dehydrogenase PyrD | 0.1871 | 1 | 0.5 |
Brugia malayi | Dihydroorotate dehydrogenase, mitochondrial precursor, putative | 0.1871 | 1 | 1 |
Toxoplasma gondii | dihydroorotate dehydrogenase reveal, putative | 0.1871 | 1 | 1 |
Echinococcus multilocularis | poly (ADP ribose) polymerase 1 | 0.0289 | 0.1102 | 0.3074 |
Wolbachia endosymbiont of Brugia malayi | dihydroorotate dehydrogenase 2 | 0.1871 | 1 | 0.5 |
Echinococcus multilocularis | dihydropyrimidine dehydrogenase (NADP+) | 0.0731 | 0.3586 | 1 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0731 | 0.3586 | 0.5 |
Echinococcus granulosus | poly adp ribose polymerase 2 | 0.0223 | 0.0729 | 0.16 |
Brugia malayi | WGR domain containing protein | 0.0289 | 0.1102 | 0.0403 |
Mycobacterium leprae | Probable dihydroorotate dehydrogenase PyrD | 0.1871 | 1 | 0.5 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0731 | 0.3586 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0192 | 0.0558 | 0.5175 |
Loa Loa (eye worm) | hypothetical protein | 0.0223 | 0.0729 | 1 |
Leishmania major | dihydroorotate dehydrogenase | 0.1871 | 1 | 0.5 |
Echinococcus granulosus | dihydropyrimidine dehydrogenase NADP | 0.0731 | 0.3586 | 1 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0731 | 0.3586 | 0.5 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.0731 | 0.3586 | 0.3082 |
Schistosoma mansoni | poly [ADP-ribose] polymerase | 0.0289 | 0.1102 | 0.0574 |
Trichomonas vaginalis | dihydropyrimidine dehydrogenase, putative | 0.0731 | 0.3586 | 0.5 |
Echinococcus multilocularis | poly (adp ribose) polymerase 2 | 0.0223 | 0.0729 | 0.2033 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0731 | 0.3586 | 0.5 |
Trypanosoma cruzi | dihydroorotate dehydrogenase (fumarate), putative | 0.1871 | 1 | 1 |
Plasmodium falciparum | dihydroorotate dehydrogenase | 0.1871 | 1 | 0.5 |
Plasmodium vivax | dihydroorotate dehydrogenase, mitochondrial precursor, putative | 0.1871 | 1 | 0.5 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.1871 | 1 | 1 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0731 | 0.3586 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.